DEF 14A

Company

Niagen Bioscience, Inc.

Filed

June 20, 2017

Period of Report

August 10, 2017

Accession Number

0001654954-17-005721

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →